Literature DB >> 1985487

Signs, complications, and platelet aggregation in familial exudative vitreoretinopathy.

C E van Nouhuys1.   

Abstract

Between 1979 and 1989, I examined 106 patients (16 pedigrees) with signs of familial exudative vitreoretinopathy. Of these patients, 101 had familial exudative vitreoretinopathy, and five had a sporadic manifestation. The complications of familial exudative vitreoretinopathy, deformation of the posterior retina, vitreous hemorrhage, amblyopia, and retinal detachment, caused diminished visual acuity. Of 170 eyes, retinal neovascularization was observed in 18 eyes (11%), and retinal exudates were observed in 16 eyes (9%). Several forms of retinal detachment occurred in 37 of 180 eyes (21%), which often took an unfavorable course. A falciform retinal fold was observed in 14 eyes (8%). Retinal surgery was performed in 14 eyes; reattachment of the retina was successful in only seven eyes. Platelet aggregation studies disclosed no significant differences between seven patients with familial exudative vitreoretinopathy and ten control subjects. The pathogenesis of the disease is based on a premature arrest of the vascular development of the retina.

Entities:  

Mesh:

Year:  1991        PMID: 1985487     DOI: 10.1016/s0002-9394(14)76893-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  21 in total

1.  [Criswick-Schepens syndrome -- familial exudative vitreoretinopathy. Report of six cases in two consanguineous families].

Authors:  A Alsheikheh; W Lieb; F Grehn
Journal:  Ophthalmologe       Date:  2004-09       Impact factor: 1.059

2.  [Familial exudative vitreoretinopathy].

Authors:  D Finis; J Stammen; A M Joussen
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

3.  [Mutations of the frizzled-4 gene. Their impact on medical care of patients with autosomal dominant exudative vitreoretinopathy].

Authors:  M Müller; C Kusserow; U Orth; U Klär-Dissars; H Laqua; A Gal
Journal:  Ophthalmologe       Date:  2008-03       Impact factor: 1.059

4.  Further evidence of genetic heterogeneity in familial exudative vitreoretinopathy; exclusion of EVR1, EVR3, and EVR4 in a large autosomal dominant pedigree.

Authors:  C Toomes; L M Downey; H M Bottomley; H A Mintz-Hittner; C F Inglehearn
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638

5.  An essential role of the cysteine-rich domain of FZD4 in Norrin/Wnt signaling and familial exudative vitreoretinopathy.

Authors:  Kang Zhang; Yuko Harada; Xinran Wei; Dhananjay Shukla; Anand Rajendran; Khaled Tawansy; Matthew Bedell; Sharon Lim; Peter X Shaw; Xi He; Zhenglin Yang
Journal:  J Biol Chem       Date:  2010-12-22       Impact factor: 5.157

6.  Familial exudative vitreoretinopathy.

Authors:  W E Benson
Journal:  Trans Am Ophthalmol Soc       Date:  1995

7.  Frizzled 4 gene (FZD4) mutations in patients with familial exudative vitreoretinopathy with variable expressivity.

Authors:  H Kondo; H Hayashi; K Oshima; T Tahira; K Hayashi
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

8.  X linked exudative vitreoretinopathy: clinical features and genetic linkage analysis.

Authors:  P Fullwood; J Jones; S Bundey; J Dudgeon; A R Fielder; M W Kilpatrick
Journal:  Br J Ophthalmol       Date:  1993-03       Impact factor: 4.638

9.  LONGITUDINAL CHANGES IN THE OPTIC NERVE HEAD AND RETINA OVER TIME IN VERY YOUNG CHILDREN WITH FAMILIAL EXUDATIVE VITREORETINOPATHY.

Authors:  Jonghyun Lee; Mays A El-Dairi; Du Tran-Viet; Shwetha Mangalesh; Alexandria Dandridge; Kim Jiramongkolchai; Christian Viehland; Cynthia A Toth
Journal:  Retina       Date:  2019-01       Impact factor: 4.256

10.  Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q.

Authors:  Carmel Toomes; Helen M Bottomley; Richard M Jackson; Katherine V Towns; Sheila Scott; David A Mackey; Jamie E Craig; Li Jiang; Zhenglin Yang; Richard Trembath; Geoffrey Woodruff; Cheryl Y Gregory-Evans; Kevin Gregory-Evans; Michael J Parker; Graeme C M Black; Louise M Downey; Kang Zhang; Chris F Inglehearn
Journal:  Am J Hum Genet       Date:  2004-03-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.